Showing posts with label global share. Show all posts
Showing posts with label global share. Show all posts

Tuesday, June 10, 2014

Erythropoietin Market - Analysis, Growth, Trends Opportunities and Forecast 2012 - 2020

Erythropoietin is a glycoprotein hormone produced in the kidney that stimulates the production of red blood cells by bone marrow stem cells. Global market of bio-similar was accounted to $2.5 billion in 2011. Increase in incidence for anemia is due to chemotherapy, and increase in the number of dialysis patients is driving the growth for erythropoietin market. According to survey conducted by anemia.org, more than 550,000 people die due to cancer, out of which 80% people suffered from anemia. Erythropoietin market growth is hindered by latency in obtaining approval of EPO drug, and high cost of EPO hormone production in in-vitro condition. For Example, Celpoirtin (10000 iu) manufactured by Pristilon (Celon Labs) injection is valued at approximately $52.
Erythropoietin market has opportunities in reducing prices for drug to tap Asian market. However, increase in abuse of application of EPO is creating restrictions for this market in developing countries. This report provides in depth analysis of current market trends of EPO in developing countries. The report gives intelligence about clinical trials conducted by companies in their respective geographies.
Key companies included in report are, Amgen Inc., Hospira Inc., Johnson & Johnson, and Roche Diagnostics.
Key Benefits
  • Market estimation for geographies is derived from current market scenario and expected market trends
  • The report provides for in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to unveil opportunities in specific regions
  • Impact analysis of top 10 factors to provide market situation to decision makers of surgical equipment market
  • Value chain analysis, Porter’s five forces, top investment pockets are analyzed and presented in detail in the report
  • SWOT analysis and strategic developments included in the report for key market players are included to get better understanding of potential opportunities and challenges for companies
Key Audiences
  • Research Institutes
  • Pharmaceutical companies
  • Academic Institutes
  • Healthcare companies

About Us:
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Tuesday, May 27, 2014

Medical Implants Market - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020


Medical implants are artificial devices that are used to replace damaged or missing biological structures. The global revenue generated by medical device manufacturing companies is over $200 billion, and more than $85 billion is accounted to the U.S. based medical device companies. The medical implants market is driven by an increase in health needs of old age people, and advancement in medical technologies.
According to the WHO, there are more than 1000 million old age people in the world, out of which 700 million are from developing countries. Increase in demand for reconstruction of joints, replacement of ophthalmic and dental market is expecting more growth in medical implant market. However, high cost of treatment and unavailability of expertise are decreasing the demand for medical implant market.

The global market for medical implants is facing problems because of uncertain reimbursement policies, influencing the importance of this market. The risk associated with genetics diseases after surgical implantation is creating hurdles for this market. This report gives intelligence about the current scenario of reimbursement policies according to geographies. The report also provides current trends of medical implants and expected growth of these trends.
For Table Of Content sales@bigmarketresearch.com

About Us:
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.


Thursday, May 22, 2014

Noninvasive Cancer Diagnostics and Technologies Market - Global Share, Analysis, Growth, Opportunities and Forecast 2012 – 2020 By Big Market Research

Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer.
According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).
The global non-invasive market has a huge potential in developing countries; however, cost of diagnosis is creating hurdles to tap this market. Hence, to overcome this problem, the diagnostic market has to be analyzed by the developing countries such as China, Japan, and India. This report provides key market drivers that are driving the market with impact analysis. The report gives intelligence about key regulatory guidelines issued by respective governments.
Key Market Segments:
Global Non-invasive cancer diagnostic market by therapeutics
       • Solid tumors
       • Blood cancer 
       • Lung Cancer       
       • Breast Cancer       
       • Others Global 
Non-invasive cancer diagnostic market by techniques  
     
 • Clinical Chemistry        
 • Immunochemistry/Immunoassay       
 • Molecular Diagnostics        
 • Other Clinical Instruments

About Us:
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Wednesday, May 21, 2014

Top 10 Noninvasive Diagnostics Market Analysis, Growth, Trends Opportunities and Forecast 2012 – 2020 By Big Market Research


Non-invasive diagnostics is a process of identifying the disease conditions with minimal incision to the body during diagnosis. Non-invasive diagnostic market is segment of diagnostic market, which was valued at approximately $46 billion in 2011. The non-invasive diagnostic market is mainly driven by increasing rate of prevalence of chronic disease such as CVD, Neurological disease. More than 64.4 million people are suffering from various type of CVD in the U.S, out of which nearly 2,600 people die in a day. The growth of non-invasive diagnostics market has been hindered by availability of non-invasive diagnostic services. Developing countries are not getting non-invasive diagnostic services due to lack of awareness.

Companies involved in manufacturing of non-invasive diagnostic tools are facing challenges because of increasing complexity of diseases. Diagnostic devices used in identification of neurological diseases require some amount of incision that make diagnostic process complex. In order to overcome these problem companies are conducting research on improving diagnostic process in neurological diseases. This report provides strategic intelligence of key developmental strategies adopted by key market players engaged in this business. The report gives patent analysis of the granted patent according to geographies.


Key Market segments
Global Non-invasive diagnostic market by technologies
  • Endoscopic devices
  • Electronic surgical devices
  • Imagining technologies
  • Monitoring and Tracking devices
  • Others
  • CVD surgery
  • Gastrointestinal Surgery
  • Obesity Surgery
  • Cosmetic surgery
  • Orthopedic surgery
  • Cryosurgery
  • Laparoscopic surgery

Global Non-invasive diagnostic market by applications
  • CVD surgery
  • Gastrointestinal Surgery
  • Obesity Surgery
  • Cosmetic surgery
  • Orthopedic surgery
  • Cryosurgery
  • Laparoscopic surgery

About Us:
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Thursday, May 8, 2014

China Medical Information System Industry Report, 2012-2014 By Big Market Research

The medical resources are insufficient and unevenly distributed in China. As large hospitals have more doctors and provide better medical services, people prefer large hospitals regardless of the severity of illness; as a result, the facilities such as bed are in serious shortage in large hospitals, while those in small hospitals and community healthcare stations are idle. However, the insufficiency, uneven distribution and low efficiency of medical resources have become a big problem in China, and the integration of medical resources has become urgent. 
For the present, Chinese Medical Information System is characterized by low market concentration and severe competition. There are no administrative barriers in its health care software market, combined with lower industrial concentration, the market share held by the top five enterprises is no more than 30%, being in the state of perfect competition. The existing domestic health care software enterprises in China can reach up to 500-600, of which, the vast majority are small-scale ones, while cross-regional national ones are rarely.
Table Of Content
1.Overview of Medical Information System
1.1 Definition of Medical Information System
1.2 Classification of Medical Information System
2. Development of Medical Information System in China
2.1 Current Situation of Medical Services
2.1.1 Medical and Health Resource Configuration is Unbalanced
2.1.2 Low Efficiency of Health Care Resources Wastes Resources
2.2 Policies of Medical Information System in China
3. Construction of International Medical Information System
3.1 Progress of Developed Countries’ Medical Information System
3.1.1 England
3.1.2 USA
3.1.3 Japan
4. Development Trend of Chinese Medical Information System
4.1 Chinese Medical Information System is Expected to Fast Grow
4.1.1 HIS, CIS will Expand the Market Capacity
4.1.2 MIS and CIS Integration is Low
4.2 Accelerated the Construction of Primary Health Institutions
5. Analysis of Key Enterprises
5.1 Winning Software
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Clients and Suppliers
About Us:

Big Market Research is an arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. Our strength is in our research analysts who with their proactive approach are able to source best and correct information which can be detrimental in organizations success. We follow six sigma standards leaving no scope for error.